Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × MDS × Other neoplasm × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Precancerous Conditions 128 Lymphoma 34 Leukemia 33 Multiple Myeloma 32 Leukemia, Lymphocytic, Chronic, B-Cell 31 Neoplasms, Plasma Cell 30 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Lymphoma, Non-Hodgkin 28 Lymphoma, Mantle-Cell 28 Lymphoma, Large-Cell, Immunoblastic 28 Lymphoma, Large B-Cell, Diffuse 28 Lymphoma, Follicular 28 Monoclonal Gammopathy of Undetermined Significance 27 Burkitt Lymphoma 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 26 Lymphoma, B-Cell, Marginal Zone 26 Hodgkin Disease 26 Myeloproliferative Disorders 25 Myelodysplastic Syndromes 25 Immunoglobulin Light-chain Amyloidosis 25 Lymphoma, T-Cell, Cutaneous 24 Leukemia, Myeloid, Acute 24 Immunoblastic Lymphadenopathy 24 Waldenstrom Macroglobulinemia 23 Lymphoma, Large-Cell, Anaplastic 23 Primary Myelofibrosis 22 Thrombocythemia, Essential 21 Leukemia, Myeloid, Chronic-Phase 21 Leukemia, Myeloid, Accelerated Phase 21 Leukemia, Large Granular Lymphocytic 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05009537 2021-08-17

CARTOGEN

University Hospital, Brest

MDS

Data powered by HemOnc (CC BY 4.0) Colophon ⚡